Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Res. 2019 Jul 25;147:104373. doi: 10.1016/j.phrs.2019.104373

Figure 7.

Figure 7.

Structures of MNPs that were subjected to various genomics based mechanism studies, including gene dosage screens (apratoxin A, aurilide, aurilide B, manzamine A and papuamide B), RNA-seq (honaucin A).